SCHEMBL95345

SCHEMBL95345

[CH2]c1ccc(NS(=O)(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
MAPT P10636 2/20 0.56
POLB P06746 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
NHERF1 O14745 1/20 0.54
MCL1 Q07820 1/20 0.54
SLC25A1 P53007 1/20 0.54
FSCN1 Q16658 1/20 0.51
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
IDH1 O75874 3/20 0.47
CA2 P00918 2/20 0.46
CA1 P00915 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HSD17B10 Q99714 1/20 0.45
HTT P42858 1/20 0.45
MAPK1 P28482 1/20 0.45
CA12 O43570 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10422318 0.86 SLC25A1 (0.66) ALDH1A1MAPTPOLBTDP1NHERF1
SCHEMBL95317 0.84 SMN1; SMN2 (0.60) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL9635088 0.82 ALDH1A1 (0.53) ALDH1A1MAPTPOLBTDP1NHERF1
SCHEMBL95927 0.80 ALDH1A1 (0.67) ALDH1A1MAPTTDP1MCL1MEN1
SCHEMBL98037 0.78 CA2 (0.71) ALDH1A1MAPTTDP1MEN1KMT2A
SCHEMBL1471788 0.77 MCL1 (0.59) ALDH1A1MAPTPOLBNHERF1MCL1
SCHEMBL5172845 0.77 NHERF1 (0.58) ALDH1A1MAPTTDP1NHERF1MCL1
SCHEMBL23832701 0.77 IDH1 (0.54) ALDH1A1MAPTPOLBNHERF1MCL1
SCHEMBL30218156 0.77 IDH1 (0.54) ALDH1A1MAPTPOLBNHERF1MCL1
SCHEMBL7580547 0.76 IDH1 (0.71) NHERF1MCL1SMN1; SMN2IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB ALDH1A1 2948/4885MAPT 4112/4885POLB 1340/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 ALDH1A1 2458/4885MAPT 4773/4885POLB 4329/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 ALDH1A1 2458/4885MAPT 4773/4885POLB 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.